Zwijnaarde, Belgium

Sam Corveleyn



 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Sam Corveleyn in Cryoprotectants for Lactic Acid Bacteria

Introduction

Sam Corveleyn is an accomplished inventor based in Zwijnaarde, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of cryoprotectants for freeze-drying lactic acid bacteria. With a total of three patents to his name, Corveleyn's work is pivotal in enhancing the viability and stability of freeze-dried bacteria.

Latest Patents

Corveleyn's latest patents focus on the discovery and development of effective cryoprotectant compositions. These compositions do not contain skim milk or any other animal-derived compounds, which is crucial for achieving long-term stability of freeze-dried lactic acid bacteria (LAB) at various temperatures. His inventions ensure that the retention of viability of the freeze-dried LAB after six months of storage, preferably after nine months, and more preferably after twelve months, exceeds 50%. This innovation is particularly relevant in the production of freeze-dried bacteria for applications in the food industry and in human or animal health. The inventions also relate to recombinant bacteria capable of expressing heterologous proteins or peptides, which can be administered for therapeutic or vaccination purposes.

Career Highlights

Corveleyn is associated with Intrexon Actobiotics N.V., where he continues to push the boundaries of biotechnology. His work has garnered attention for its potential applications in various industries, including food production and healthcare.

Collaborations

Some of his notable coworkers include Patrick Dhaese and Sabine Neirynck, who contribute to the innovative environment at Intrexon Actobiotics N.V.

Conclusion

Sam Corveleyn's contributions to the field of cryoprotectants for lactic acid bacteria represent a significant advancement in biotechnology. His innovative approaches are set to impact various sectors, particularly in enhancing the viability of freeze-dried bacteria for health and food applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…